Reduction in morbidity and mortality from childhood diarrhoeal disease after species a rotavirus vaccine introduction in Latin America - A review

Memorias do Instituto Oswaldo Cruz

Volumn 106, Issue 8, 2011, Pages 907-911

  Desai, Rishi ^a   de Oliveira, Lucia Helena ^b   Parashar, Umesh D ^a   Lopman, Benjamin ^a   Tate, Jacqueline E ^a   Patel, Manish M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b PAN AMERICAN HEALTH ORGANIZATION   (United States)

Author keywords

Latin America; Rotavirus; Species a rotavirus; Vaccines

Indexed keywords

ROTAVIRUS;

EID: 84855487359     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762011000800002     Document Type: Editorial

References (27)

1. Buttery JP, Danchin MH, Lee KJ, Carlin JB, McIntyre PB, Elliott EJ, Booy R, Bines JE, PAEDS/APSU Study Group 2011. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine 29: 3061-3066.
2. Carvalho-Costa FA, Volotão E de M, de Assis RM, Fialho AM, de Andrade J da S, Rocha LN, Tort LF, da Silva MF, Gómez MM, de Souza PM, Leite JP 2011. Laboratory-based rotavirus surveillance during the introduction of a vaccination program, Brazil, 2005-2009. Pediatr Infect Dis J 30 (Suppl. 1): S35-S41.
3. Colindres RE 2010. GSK human rotavirus vaccine Rotarix: PASS Mexico study update. Presented at the Advisory Committee on Immunization Practices Meeting, Atlanta, GA, USA. Available from: http//cdc.gov/vaccines/recs/acip/slides-oct10.htm.
4. Correia JB, Patel MM, Nakagomi O, Montenegro FM, Germano EM, Correia NB, Cuevas LE, Parashar UD, Cunliffe NA, Nakagomi T 2010. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhoea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis 201: 363-369.
5. de Palma O, Cruz L, Ramos H, de Baires A, Villatoro N, Pastor D, de Oliveira LH, Kerin T, Bowen M, Gentsch J, Esposito DH, Pa-rashar U, Tate J, Patel M 2010. Effectiveness of rotavirus vacci-nation against childhood diarrhoea in El Salvador: case-control study. BMJ 340: c2825.
6. do Carmo GM, Yen C, Cortes J, Siqueira AA, de Oliveira WK, Cortez-Escalante JJ, Lopman B, Flannery B, de Oliveira LH, Carmo EH, Patel M 2011. Decline in diarrhoea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med 8: e1001024.
7. GAVI Alliance 2011. Vaccines against major childhood diseases to reach 37 more countries. Available from: http//gavialliance.org/library/news/press-releases/2011/vaccines-against-major-childhood-diseases-to-reach-37-more-countries/.
8. Gurgel RQ, Cuevas LE, Vieira SC, Barros VC, Fontes PB, Salustino EF, Nakagomi O, Nakagomi T, Dove W, Cunliffe N, Hart CA 2007. Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg Infect Dis 13: 1571-1573.
9. Jiang V, Jiang B, Tate J, Parashar UD, Patel MM 2010. Performance of rotavirus vaccines in developed and developing countries. Hum Vaccin 6: 532-542.
10. Justino MC, Linhares AC, Lanzieri TM, Miranda Y, Mascarenhas JD, Abreu E, Guerra SF, Oliveira AS, da Silva VB, Sanchez N, Meyer N, Shafi F, Ortega-Barria E, Soriano-Gabarró M, Colindres RE 2011. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil. Pediatr Infect Dis J 30: 396-401.
11. Lanzieri TM, Costa I, Shafi FA, Cunha MH, Ortega-Barria E, Li-nhares AC, Colindres RE 2010. Trends in hospitalizations from all-cause gastroenteritis in children younger than 5 years of age in Brazil before and after human rotavirus vaccine introduction, 1998-2007. Pediatr Infect Dis J 29: 673-675.
12. Lanzieri TM, Linhares AC, Costa I, Kolhe DA, Cunha MH, Ortega-Barria E, Colindres RE 2011. Impact of rotavirus vaccination on childhood deaths from diarrhoea in Brazil. Int J Infect Dis 15: e206-210.
13. Lopman BA, Curns AT, Yen C, Parashar UD 2011. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis 204: 980-986.
14. Molto Y, Cortes JE, De Oliveira LH, Mike A, Solis I, Suman O, Coronado L, Patel MM, Parashar UD, Cortese MM 2011. Reduction of diarrhoea-associated hospitalizations among children aged < 5 years in Panama following the introduction of rotavirus vaccine. Pediatr Infect Dis J 30 (Suppl. 1): S16-20.
15. Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, Birmingham M, Glass RI 2009. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 200 (Suppl. 1): S9-S15.
16. Patel M, Pedreira C, De Oliveira LH, Tate J, Orozco M, Mercado J, Gonzalez A, Malespin O, Amador JJ, Umaña J, Balmaseda A, Perez MC, Gentsch J, Kerin T, Hull J, Mijatovic S, Andrus J, Parashar U 2009. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhoea among children in Nicaragua. JAMA 301: 2243-2251.
17. Patel MM, López-Collada VR, Bulhões MM, De Oliveira LH, Bautista Márquez A, Flannery B, Esparza-Aguilar M, Montenegro Renoiner EI, Luna-Cruz ME, Sato HK, Hernández-Hernández L del C, Toledo-Cortina G, Cerón-Rodríguez M, Osnaya-Romero N, Martínez-Alcazar M, Aguinaga-Villasenor RG, Plascencia-Hernández A, Fojaco-González F, Hernández-Peredo Rezk G, Gutierrez-Ra-mírez SF, Dorame-Castillo R, Tinajero-Pizano R, Mercado-VillegasB, Barbosa MR, Maluf EM, Ferreira LB, de Carvalho FM, dos Santos AR, Cesar ED, de Oliveira ME, Silva CL, de Los Angeles Cortes M, Ruiz Matus C, Tate J, Gargiullo P, Parashar UD 2011. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med 364: 2283-2292.
18. Quintanar-Solares M, Yen C, Richardson V, Esparza-Aguilar M, Pa-rashar UD, Patel MM 2011. Impact of rotavirus vaccination on diarrhea-related hospitalizations among children < 5 years of age in Mexico. Pediatr Infect Dis J 30 (Suppl. 1): S11-S15.
19. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, Esparza-Aguilar M, Johnson B, Gomez-Altamirano CM, Parashar U, Patel M 2010. Effect of rotavirus vaccination on death from childhood diarrhoea in Mexico. N Engl J Med 362: 299-305.
20. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, CervantesY, Linhares AC, López P, Macías-Parra M, Ortega-Barría E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pavía-Ruz N, Salmerón J, Rüttimann R, Tinoco JC, Rubio P, Nuñez E, Guerrero ML, Yarzábal JP, Damaso S, Tornieporth N, Sáez-Llorens X, Vergara RF, Vesikari T, Bouckenooghe A, Clemens R, De Vos B, O'Ryan M, Human Rotavirus Vaccine Study Group 2006. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354: 11-22.
21. Sáfadi MA, Berezin EN, Munford V, Almeida FJ, de Moraes JC, Pi-nheiro CF, Racz ML 2010. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil. Pediatr Infect Dis J 29: 1019-1022.
22. Soares-Weiser K, Maclehose H, Ben-Aharon I, Goldberg E, Pitan F, Cunliffe N 2010. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev 5: CD008521.
23. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM, Rotavirus Efficacy and Safety Trial (REST) Study Team 2006. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354: 23-33.
24. WHO - World Health Organization 2007. Rotavirus vaccines. Wkly Epidemiol Rec 82: 285-295.
25. WHO - World Health Organization 2010. Statement on Rotarix and Rotateq vaccines and intussusception. Global Advisory Committee on Vaccine Safety. Available from: http//who.int/vaccine_safety/topics/rotavirus/rotarix_and_rotateq/intussusception_sep2010/en/index.html.
26. Yen C, Armero Guardado JA, Alberto P, Rodriguez Araujo DS, Mena C, Cuellar E, Nolasco JB, De Oliveira LH, Pastor D, Tate JE, Parashar UD, Patel MM 2011a. Decline in rotavirus hospitalizations and health care visits for childhood diarrhoea following rotavirus vaccination in El Salvador. Pediatr Infect Dis J 30 (Suppl. 1): S6-S10.
27. Yen C, Figueroa JR, Uribe ES, Carmen-Hernández LD, Tate JE, Parashar UD, Patel MM, Richardson López-Collado V 2011b. Monovalent rotavirus vaccine provides protection against an emerging fully heterotypic G9P[4] rotavirus strain in Mexico. J Infect Dis 204: 783-786.